Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Health Canada has approved the first generic semaglutide injection for weight loss.

Dr. Reddy's Laboratories (NYSE:RDY) said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide ...

Sun Pharma received SAHPRA approval to manufacture and market generic semaglutide injections for type 2 diabetes treatment in ...

Sun Pharmaceutical Industries Ltd  on Wednesday said it has received approval from  South African regulator to manufacture ...

Sun Pharmaceutical shares hit a 52-week high after receiving approval to market generic semaglutide injection in South Africa ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Drugmaker Sun Pharmaceutical Industries has received the green signal from the South African Health Products Regulatory ...

Sun Pharmaceutical Industries has secured SAHPRA approval to launch its generic semaglutide injection for type 2 diabetes treatment, marking its second market entry after India.

The arrival of generic semaglutide in India was expected to make obesity and diabetes treatment more affordable and ...

By Rishika Sadam and Kashish Tandon July 9 (Reuters) - India's Dr Reddy's Laboratories said on Thursday that supplies of its ...